Cat.#: ACPP-1826
| Despition | CRYGN Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1113 | Native Porcine GFAP Protein (AC1113) | 25 µl | inquiry |
| ACPP-1393 | Human ALDH3A1 Protein (AC1393) | 2 µg | inquiry |
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1356 | GIRK2 Blocking Peptide (AC1356) | 250 µg | inquiry |
| ACPP-1193 | Human M2 Protein (AC1193) | 5 µg | inquiry |
| ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
| ACPP-1783 | Human SAT2 Protein (AC1783) | 5 µg | inquiry |
| ACPP-1386 | Human HMGN1 Protein (AC1386) | 2 µg | inquiry |
| ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
| ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.